Home » Topics » Regulatory » Patents

Patents
RSS

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

NOS inhibitors claimed by Schering AG for CNS disorders

April 1, 1998

Bayer investigates CETP inhibitors as hypolipidemic/antiatherosclerotic agents

April 1, 1998

Antibacterial quinolone carboxylic acids prepared at Bayer

April 1, 1998

Novel antiosteoporotic compound discovered by AHP

April 1, 1998

Anticoagulants in development at DuPont Merck

April 1, 1998

Antiarrhythmic Na+/H+ exchange inhibitors prepared by Hoechst

March 31, 1998

Focus on agents for estrogen deprivation continues at Lilly

March 30, 1998

SKB develops new agents for osteoporosis and related disorders

March 30, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...